Status:
RECRUITING
The Effect of Short-term Supplementation of OliPhenolia® on Fat Oxidation.
Lead Sponsor:
Anglia Ruskin University
Conditions:
Healthy
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
There is current research interest in the use of fruit and plant-based food products containing high levels of natural antioxidants and their impact on exercise, which may be particularly beneficial f...
Detailed Description
This exploratory study will involve initial recruitment of approximately 30-40 healthy volunteers to undertake an initial study briefing pre-screening health questionnaire, informed written consent an...
Eligibility Criteria
Inclusion
- Men and women, UK based, above 21 years of age with a body mass index (BMI) \>18 and \<30 kg·m2 determined during baseline testing
- Considered to be recreationally active i.e. approximately 150mins of general physical activity/ exercise per week (meeting the WHO physical activity guidelines); and a VO2peak (fitness) score \>20 and \<50 mL·kg-1·min-1 determined during baseline testing.
- No known history (including family history) of heart abnormalities, hypertension, coronary heart disease or diabetes (determined from pre-study health screen questionnaire).
- Not currently suffering from any musculoskeletal injury, or any other reason that may prevent participation in cardiovascular exercise.
- Have not suffered from recent viral infections ie: influenza (defined within the prior 2 months).
- Not taking any prescribed or over-the-counter medication which may influence exercise training (with the exception of inhalers for exercise induced asthma or contraceptive pill).
- Not consuming or prepared to refrain from consumption, any commercial supplementation which conflicts with the study parameters ie: antioxidants.
- No known allergy or intolerance to olives or prune/grape juice, or any known side effects from caffeine ingestion.
Exclusion
- If any of the above criteria is not met.
Key Trial Info
Start Date :
May 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07210099
Start Date
May 30 2025
End Date
March 30 2026
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University,
Cambridge, United Kingdom, CB1 1PT